sj-docx-1-tam-10.1177_17588359221146137 – Supplemental material for Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis

Yoshino, Takayuki; Taieb, Julien; Kuboki, Yasutoshi; Pfeiffer, Per; Kumar, Amit; Hochster, Howard S.

doi:10.25384/SAGE.21986062.v1

sj-docx-1-tam-10.1177_17588359221146137.docx (343.61 kB)

sj-docx-1-tam-10.1177_17588359221146137 – Supplemental material for Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis

journal contribution

posted on 2023-02-01, 01:35 authored by Takayuki Yoshino, Julien Taieb, Yasutoshi Kuboki, Per Pfeiffer, Amit Kumar, Howard S. Hochster

Supplemental material, sj-docx-1-tam-10.1177_17588359221146137 for Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis by Takayuki Yoshino, Julien Taieb, Yasutoshi Kuboki, Per Pfeiffer, Amit Kumar and Howard S. Hochster in Therapeutic Advances in Medical Oncology